Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma
- 1 November 2006
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 243 (1) , 32-37
- https://doi.org/10.1016/j.canlet.2005.11.016
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development GroupAnnals of Oncology, 2004
- Mistletoe for cancer?International Journal of Cancer, 2003
- Identification of the Ricin Lipase Site and Implication in CytotoxicityJournal of Biological Chemistry, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Inhibition of Tumor Growth and Metastasis by Korean Mistletoe Lectin is Associated with Apoptosis and AntiangiogenesisCancer Biotherapy & Radiopharmaceuticals, 2001
- Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.Journal of Clinical Investigation, 1998
- Primary Structure and Molecular Modeling of Mistletoe Lectin I fromViscum albumBiochemical and Biophysical Research Communications, 1998
- Mistletoe Lectin I-Induced Effects on Human Cytotoxic Lymphocytes. I. Synergism with Il-2 in the Induction of Enhanced Lak CytotoxicityImmunopharmacology and Immunotoxicology, 1998
- IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine ResponsesImmunity, 1996
- Th1 type CD4+ T cells may be a potent effector against poorly immunogenic syngeneic tumorsBiotherapy, 1994